Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, announced that blood-based NfL measurements provided compelling support for the...
In a global effort to better understand and effectively treat Alzheimer's disease, Embic and the Alzheimer's Disease Neuroimaging Initiative (ADNI) have partnered to provide...
Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1.
Also Read:...
